Artivion (Artivion) Risk Assessment

View and export this data going back to 1993. Start your Free Trial

What is Artivion Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Artivion is: High Risk: High uncertainty with risk-return tradeoff.

Competitive Comparison of Artivion's Risk Assessment

For the Medical Devices subindustry, Artivion's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Artivion's Risk Assessment Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Artivion's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Artivion's Risk Assessment falls into.

Artivion (NYSE:AORT) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Artivion Risk Assessment Related Terms

Thank you for viewing the detailed overview of Artivion's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Artivion (Artivion) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Artivion Inc (NYSE:AORT) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

CYL:Germany

Address

1655 Roberts Boulevard North West, Kennesaw, GA, USA, 30144

Website

https://www.artivion.com

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others.

Executives

Jean F Holloway	officer: VP, General Counsel	C/O ARTIVION INC, 1655 ROBERTS BLVD, KENNESAW GA 30144
John E Davis	officer: Senior VP, Global Sales	1655 ROBERTS BLVD., NW, KENNESAW GA 30144
Amy Horton	officer: Chief Accounting Officer	C/O CRYOLIFE, INC., 1655 ROBERTS BLVD., NW, KENNESAW GA 30144
Florian Tyrs	officer: VP, Global Operations	IM SOELLER 3, BALINGEN 2M 72336
Robert C Thomson	officer: VP Research & Development	33 HABERSHAM COVE DRIVE, NW, ATLANTA GA 30305
Matthew A Getz	officer: VP, Human Resources	1655 ROBERTS BLVD NW, KENNESAW GA 30144
Dennis B Maier	officer: Vice President, Operations	1655 ROBERTS BLVD, NW, KENNESAW GA 30144
Rochelle L. Maney	officer: VP, Quality	1655 ROBERTS BLVD, NW, KENNESAW GA 30144
James P Mackin	officer: President & CEO	ARTIVION, INC., 1655 ROBERTS BLVD, NW, KENNESAW GA 30144
Marshall S. Stanton	officer: SVP, Clinical & MD Affair	1655 ROBERTS BLVD, NW, KENNESAW GA 30144
Andrew M Green	officer: VP Regulatory	ARTIVION INC, 1655 ROBERTS BLVD, KENNESAW GA 30144
David Ashley Lee	officer: Executive VP, COO & CFO	C/O CRYOLIFE INC, 1655 ROBERTS BLVD NW, KENNESAW GA 30144
Elizabeth A Hoff	director	2701 WESTHEIMER ROAD, UNIT 1-E, HOUSTON TX 77098
Anthony B. Semedo	director	3288 HARRISON GRADE ROAD, SEBASTOPOL CA 95472
Ronald D Mccall	director	C/O CRYOLIFE, INC., 1655 ROBERTS BOULEVARD, NW, KENNESAW GA 30144